Cordis Corporation

14201 NW 60th Avenue
Miami Lakes
FL
33014
USA
http://www.cordis.com

Related Articles

Cath Lab

European Peripheral Vascular Device Market to Grow Strongly Through 2017
Predicting the Cath Lab of the Future
Bioresorbable Vascular Closure Devices Speed Ambulation
Editor’s Choice for Most Innovative Technology at ACC 2012
Robotic Cath Lab Navigation System Begins FDA Trial
Cordis, Boston Scientific 14 Stent, Balloon Patent Lawsuits

Peripheral Arterial Disease (PAD) Treatment Devices

European Peripheral Vascular Device Market to Grow Strongly Through 2017
SMART Vascular Stent Systems Receive FDA Approval for Use in SFA

Stents, Peripheral

SMART Vascular Stent Systems Receive FDA Approval for Use in SFA
Cardiovascular Stents – Novel Designs, Polymers and New Entries into Market Top Industry Trends

Flat Panel Displays

Predicting the Cath Lab of the Future

FFR Catheters

Predicting the Cath Lab of the Future

Ultrasound, Transesophageal (TEE)

Predicting the Cath Lab of the Future

Angiography Systems

Predicting the Cath Lab of the Future
Editor’s Choice for Most Innovative Technology at ACC 2012
Robots Arrive to Open Arms in the Cath Lab – the Future is Almost Here

Heart Valve Repair

Predicting the Cath Lab of the Future
Editor’s Choice for Most Innovative Technology at ACC 2012

Hybrid OR

Predicting the Cath Lab of the Future

Hemostasis Management

Bioresorbable Vascular Closure Devices Speed Ambulation

Vascular Closure Devices

Bioresorbable Vascular Closure Devices Speed Ambulation
Cordis Begins Trial for New Vascular Closure Device

Cardiovascular Ultrasound

Editor’s Choice for Most Innovative Technology at ACC 2012

Ultrasound, Intra-cardiac echo (ICE)

Editor’s Choice for Most Innovative Technology at ACC 2012

Cardiac PACS

Editor’s Choice for Most Innovative Technology at ACC 2012

Cardiology Data Management System

Editor’s Choice for Most Innovative Technology at ACC 2012

Advanced Visualization

Editor’s Choice for Most Innovative Technology at ACC 2012

EP Mapping/Imaging Systems

Editor’s Choice for Most Innovative Technology at ACC 2012

Stents, Drug Eluting

The Future of Coronary Stenting
Court Rules in Favor of Boston Scientific in Stent Lawsuit
Cardiovascular Stents – Novel Designs, Polymers and New Entries into Market Top Industry Trends
The Next Generation of DES
Cordis Discontinues Cypher Stent, Halts Development of Nevo Stent
Stent With Tiny Reservoirs Shows Good Safety, Efficacy
Stent Makers Settle Three Patent Disputes for $1.7 Billion
Stent Fracture More Common Than Previously Believed
Cordis, Boston Scientific 14 Stent, Balloon Patent Lawsuits
First Patient Enrolled in CYPRESS Dual Anti-Platelet Therapy Trial with CYPHER
NEVO, XIENCE DES Will Go Head-to-Head in New Clinical Trial
CYPHER SELECT Plus Sirolimus-eluting Stent Approved in the EU for Treatment of Diabetes Patients
The CYPHER Sirolimus-Eluting Stent Outperforms the Taxus in People with Diabetes in New Data
CYPHER SELECT Plus Sirolimus-Eluting Coronary Stent Receives CE Mark for Heart Attacks
Drug-Eluting Stent Outperforms Bare Metal Says Study
Stent Reduces MACE by 55 Percent
Stent Used as Alternative to Surgery for Multivessel Disease
ESC Congress Says Cypher DES Sustains Clinical Benefits
Sanctions Lifted on Cordis' Drug-Coated Heart Stents
Cordis to Gain Conor Stent Technology
Drug-Eluting Stent Features Hydrophilic Coating Technology
Stent Specifically Designed to Prevent Restenosis
Label Affirms No Increased Heart Attack Risk

Stents, Bare Metal

The Future of Coronary Stenting
Cardiovascular Stents – Novel Designs, Polymers and New Entries into Market Top Industry Trends
Next-Generation Coronary Stent Launched in Europe

Stents, Bioresorbable

The Future of Coronary Stenting
Cardiovascular Stents – Novel Designs, Polymers and New Entries into Market Top Industry Trends

Stents

The Future of Coronary Stenting
Court Rules in Favor of Boston Scientific in Stent Lawsuit
Cardiovascular Stents – Novel Designs, Polymers and New Entries into Market Top Industry Trends
The Next Generation of DES
Cordis Discontinues Cypher Stent, Halts Development of Nevo Stent
Cordis Enters Distribution Agreement for Ostial Stent Positioning System
Stent With Tiny Reservoirs Shows Good Safety, Efficacy
Stent Makers Settle Three Patent Disputes for $1.7 Billion
Stent Fracture More Common Than Previously Believed
Cordis, Boston Scientific 14 Stent, Balloon Patent Lawsuits
The CYPHER Sirolimus-Eluting Stent Outperforms the Taxus in People with Diabetes in New Data
CYPHER SELECT Plus Sirolimus-Eluting Coronary Stent Receives CE Mark for Heart Attacks
Study Shows Significant Reduction in Blood Clots and Reintervention With Cypher Sirolimus-eluting Coronary Stent
Cordis Receives FDA Humanitarian Device Exemption for Vessel Reconstruction System
Sanctions Lifted on Cordis' Drug-Coated Heart Stents
Cordis Receives FDA Humanitarian Device Exemption for Vessel Reconstruction System
Stent, Guide Wire Treat CAD in Patients at High Risk from CEA
Label Affirms No Increased Heart Attack Risk

Stents, Carotid

Cardiovascular Stents – Novel Designs, Polymers and New Entries into Market Top Industry Trends
Cordis Releases New Nitinol Self-Expanding Stent
Cordis Releases New Version Carotid Stenting System

Introducer Sheaths

Cordis Launches Solutions for Transradial Care
Cordis Recalls CROSSOVER Sheath Introducer Due to Fractures
Radialsource Transradial Sheath

Radial Access

Cordis Launches Solutions for Transradial Care
Radialsource Transradial Sheath

Robotic Systems, Cath Lab

Robots Arrive to Open Arms in the Cath Lab – the Future is Almost Here

Navigation Aids, Cath Lab

Robots Arrive to Open Arms in the Cath Lab – the Future is Almost Here
Robotic Cath Lab Navigation System Begins FDA Trial
Cordis Enters Distribution Agreement for Ostial Stent Positioning System

Clinical Trial/Study

Stent With Tiny Reservoirs Shows Good Safety, Efficacy
Stent Fracture More Common Than Previously Believed
First Patient Enrolled in CYPRESS Dual Anti-Platelet Therapy Trial with CYPHER
NEVO, XIENCE DES Will Go Head-to-Head in New Clinical Trial

Aneurism repair devices (AAA, TAA)

Trial Explores Smaller Stent Grafts for Abdominal Aortic Aneurisms

Stent Grafts

Trial Explores Smaller Stent Grafts for Abdominal Aortic Aneurisms
Cordis Receives FDA Humanitarian Device Exemption for Vessel Reconstruction System
Cordis Receives FDA Humanitarian Device Exemption for Vessel Reconstruction System

Pharmaceuticals

First Patient Enrolled in CYPRESS Dual Anti-Platelet Therapy Trial with CYPHER

Cardiology Products

NEVO, XIENCE DES Will Go Head-to-Head in New Clinical Trial
The CYPHER Sirolimus-Eluting Stent Outperforms the Taxus in People with Diabetes in New Data
CYPHER SELECT Plus Sirolimus-Eluting Coronary Stent Receives CE Mark for Heart Attacks

General Cardiology

The CYPHER Sirolimus-Eluting Stent Outperforms the Taxus in People with Diabetes in New Data
CYPHER SELECT Plus Sirolimus-Eluting Coronary Stent Receives CE Mark for Heart Attacks

Catheters

Cordis Expands PTCA Portfolio with SLEEK, SAVVY
New Balloon Catheter for Carotid, Renal Angioplasty Hits Market
Cordis Rolls Out New Dilatation Catheter in Europe
Cordis Rolls Out New Dilatation Catheter in Europe
Cordis, ClearStream to Co-Distribute PTA Balloon Catheters
Re-Entry Catheters Facilitate Wire Placement in Endovascular Procedures to Treat CTOs

Balloon Catheter

Cordis Delivers New Balloons to U.S. Market
Cordis Delivers New Balloons to U.S. Market
New Balloon Catheter for Carotid, Renal Angioplasty Hits the Market

Embolization devices

Cordis Receives FDA Humanitarian Device Exemption for Vessel Reconstruction System
Cordis Receives FDA Humanitarian Device Exemption for Vessel Reconstruction System